NGNE
#2779
Neurogene Inc. - Common Stock
39.1 4 USD
+0.02%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
+2.14%
Variación mensual
+33.40%
Variación en los últimos 6 meses
+107.64%
Cambio anual
+33.04%
Cierres anteriores
38.3 2
Open
38.4 3
Mínimo
38.4 3
High
39.4 5
Volumen
309
Financials
- Market Capitalization 618.49 M
- Employee 131
- Founded 2018
- CEO Jonathan Drachman M.D.
- Website www.neurogene.com
- Headquarter New York, United States
- FIGI BBG005Y0QDK1
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-4.86
Relación precio/flujo de caja
—
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 2769 |  GYRE Gyre Therapeutics, Inc. - Common Stock | 6.34 USD | 0.00% | -9.56% | +6.55% | -23.24% | 615.16 M USD | ||
| 2773 |  MDXG MiMedx Group, Inc - Common Stock | 4.21 USD | +3.19% | +0.24% | +15.34% | -32.75% | 627.06 M USD | ||
| 2781 |  FDMT 4D Molecular Therapeutics, Inc. - Common Stock | 11.71 USD | +3.63% | -8.66% | +29.54% | +3.63% | 612.15 M USD | ||
| 2795 |  FBRX Forte Biosciences, Inc. - Common Stock | 43.39 USD | -1.65% | +95.01% | +144.59% | +47.84% | 602.50 M USD |